How Cartels Are Repositioning into Africa
The globalization of illicit supply chains is entering a new phase, according to an ADF piece titled “Cartels Shift Drug Manufacturing to Africa.” What was once a transit problem for Africa is now a production problem. The shift of cartel-linked drug manufacturing into states like South Africa and Nigeria reflects adaptive behavior under pressure, not expansion for its own sake.
South African authorities have uncovered industrial-scale methamphetamine labs tied to Mexican networks, signaling a doctrinal shift in cartel operations. As Andy Mashaile, a security strategist and retired Interpol ambassador, observed:
“There is a concerted effort by transnational organized crime gangs, specifically manufacturing drugs, and we are seeing a change in their modus operandi,”
This relocation of production closer to end markets reduces interdiction risk while exploiting governance gaps. It also reflects a broader displacement effect. Pressure in the Americas is redistributing networks as opposed to eliminating them.
“Criminal networks facing shrinking space in the Americas will look for other spaces where risk is lower and returns are opaque.”
Africa offers precisely that environment. Weak institutional resilience, porous borders, and entrenched trafficking corridors create permissive conditions. The Interpol-linked assessments and the Africa Organized Crime Index reinforce how most states lack the capacity to counter this evolution.
This is a convergence problem involving organized crime, governance, and security force capacity.
“South Africa’s organized crime landscape is evolving faster than the country can build the institutional capacity needed to address it.”
Without coordinated international engagement, Africa risks becoming a cornerstone of global synthetic drug production.
While you’re here…
Check out this thought-provoking perspective piece by Jim Crotty: “Could Mexican Cartels Be Incentivized to Sell “Safer” Drugs?“
